Why the study?
Does in-hospital influenza vaccination reduce death and cardiovascular outcomes in patients with STEMI or non-STEMI?
Does in-hospital influenza vaccination reduce death and cardiovascular outcomes in patients with STEMI or non-STEMI?
The IAMI trial is designed to evaluate the efficacy of in-hospital influenza vaccination as secondary prevention after acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
IAMI RCT tests in-hospital influenza vaccination post-MI; provides first direct evidence on secondary prevention strategy.
The IAMI trial is the largest randomized trial to date to evaluate the effect of in-hospital influenza vaccination on death and cardiovascular outcomes in patients with STEMI or non-STEMI. The trial is expected to provide highly relevant clinical data on the efficacy of influenza vaccine as secondary prevention after AMI.
No takes yet. Share an insight, caveat, or question.
Fröbert et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: